Comprehensive Biochemistry Study Guide: Glycolysis, Regulation, and Metabolic Pathology

Functions and Overview of Glycolysis

• Definition and Universal Role: Glycolysis is the fundamental metabolic pathway present in all human cells that oxidizes glucose into pyruvate to generate cellular energy in the form of Adenosine Triphosphate ($\text{ATP}$).
• Glucose Transport and Trapping: Cellular uptake of extracellular glucose is facilitated by Glucose Transporters ($\text{GLUTs}$). Upon entering the cytosol, glucose is immediately trapped intracellularly by irreversible phosphorylation to Glucose 6-phosphate ($\text{Glucose 6-P}$).
• Erythrocyte Dependency: Red blood cells (erythrocytes) completely lack mitochondria and are strictly reliant on glycolysis as their sole source of $\text{ATP}$ generation.
• Primary Functions of Glycolysis:
  • Primary cellular pathway for energy ($\text{ATP}$) production from glucose.
  • Major route for metabolizing dietary monosaccharides, including fructose and galactose.
  • Generates pyruvate as a precursor for mitochondrial oxidation in the Tricarboxylic Acid ($\text{TCA}$) cycle.
  • Supplies intermediate compounds that serve as essential carbon skeletons for biosynthetic and anabolic pathways.

Complete Step-by-Step Glycolytic Pathway

• The pathway is divided into two major phases: Phase I (Preparative or Priming Stage) and Phase II ($\text{ATP}$-Generating or Payoff Stage).

• Phase I: Preparative / Priming Stage (Steps 1–5):

  • Step 1: Phosphorylation of Glucose
  • Reaction: $\text{D-Glucose} + \text{ATP} \rightarrow \text{Glucose 6-phosphate} + \text{ADP} + \text{H}^+$
  • Enzymes: Hexokinase (expressed in most extrahepatic tissues) or Glucokinase (expressed in liver and pancreatic $\beta\text{-cells}$).
  • Function: Traps glucose intracellularly and maintains the concentration gradient favoring glucose entry. Consumes $1\,\text{ATP}$.
  • Step 2: Isomerization of Glucose 6-phosphate
  • Reaction: $\text{Glucose 6-phosphate} \rightleftharpoons \text{Fructose 6-phosphate}$
  • Enzyme: Phosphoglucose isomerase.
  • Function: Isomerizes an aldose sugar ($\text{Glucose 6-P}$) into a ketose sugar ($\text{Fructose 6-P}$).
  • Step 3: Phosphorylation of Fructose 6-phosphate
  • Reaction: $\text{Fructose 6-phosphate} + \text{ATP} \rightarrow \text{Fructose 1,6-bisphosphate} + \text{ADP} + \text{H}^+$
  • Enzyme: Phosphofructokinase-1 ($\text{PFK-1}$).
  • Function: Represents the primary rate-limiting and committed step of glycolysis. Consumes $1\,\text{ATP}$.
  • Step 4: Aldol Cleavage of Fructose 1,6-bisphosphate
  • Reaction: $\text{Fructose 1,6-bisphosphate} \rightleftharpoons \text{Dihydroxyacetone phosphate} + \text{Glyceraldehyde 3-phosphate}$
  • Enzyme: Aldolase.
  • Function: Cleaves the six-carbon bisphosphate intermediate into two distinct three-carbon triose phosphates.
  • Step 5: Isomerization of Triose Phosphates
  • Reaction: $\text{Dihydroxyacetone phosphate} \rightleftharpoons \text{Glyceraldehyde 3-phosphate}$
  • Enzyme: Triose phosphate isomerase.
  • Net Yield of Phase I: Conversion of $1\,\text{Glucose}$ molecule into $2\,\text{Glyceraldehyde 3-phosphate}$ molecules, consuming $2\,\text{ATP}$.

• Phase II: ATP-Generating Stage (Steps 6–10):

  • Note: Stoichiometry is multiplied by 2 for each glucose molecule that enters glycolysis.
  • Step 6: Oxidation and Phosphorylation of Glyceraldehyde 3-phosphate
  • Reaction: $\text{Glyceraldehyde 3-phosphate} + \text{P}_i + \text{NAD}^+ \rightleftharpoons \text{1,3-Bisphosphoglycerate} + \text{NADH} + \text{H}^+$
  • Enzyme: Glyceraldehyde 3-phosphate dehydrogenase ($\text{G3PDH}$).
  • Function: Oxidizes the aldehyde group to create a high-energy acyl-phosphate bond using inorganic phosphate ($\text{P}_i$) while reducing $\text{NAD}^+$ to $\text{NADH}$.
  • Step 7: First Substrate-Level Phosphorylation
  • Reaction: $\text{1,3-Bisphosphoglycerate} + \text{ADP} \rightleftharpoons \text{3-Phosphoglycerate} + \text{ATP}$
  • Enzyme: Phosphoglycerate kinase.
  • Function: Transfers the high-energy acyl-phosphate group to $\text{ADP}$, generating $2\,\text{ATP}$ per glucose molecule.
  • Step 8: Isomerization of 3-Phosphoglycerate
  • Reaction: $\text{3-Phosphoglycerate} \rightleftharpoons \text{2-Phosphoglycerate}$
  • Enzyme: Phosphoglyceromutase.
  • Function: Shifts the phosphate ester from carbon 3 to carbon 2.
  • Step 9: Dehydration of 2-Phosphoglycerate
  • Reaction: $\text{2-Phosphoglycerate} \rightleftharpoons \text{Phosphoenolpyruvate} + \text{H}_2\text{O}$
  • Enzyme: Enolase.
  • Function: Removes a water molecule to generate Phosphoenolpyruvate ($\text{PEP}$), which contains a high-energy enolic phosphate bond.
  • Step 10: Second Substrate-Level Phosphorylation
  • Reaction: $\text{Phosphoenolpyruvate} + \text{ADP} + \text{H}^+ \rightarrow \text{Pyruvate} + \text{ATP}$
  • Enzyme: Pyruvate kinase.
  • Function: Irreversibly transfers phosphate to $\text{ADP}$, producing pyruvate and generating $2\,\text{ATP}$ per glucose molecule.

• Net Stoichiometry and Energy Balance:

  • Overall Net Reaction:     $\text{Glucose} + 2\,\text{NAD}^+ + 2\,\text{ADP} + 2\,\text{P}_i \rightarrow 2\,\text{Pyruvate} + 2\,\text{NADH} + 2\,\text{H}^+ + 2\,\text{ATP} + 2\,\text{H}_2\text{O}$
  • Energy Summary: $4\,\text{ATP}$ generated in Phase II minus $2\,\text{ATP}$ consumed in Phase I yields a net gain of $2\,\text{ATP}$ per glucose molecule.

Aerobic versus Anaerobic Glycolysis

• Aerobic Glycolysis:

  • Requires adequate oxygen supply ($\text{O}_2$) and functional mitochondria.
  • Final product: Pyruvate.
  • Fate of Pyruvate: Transported into the mitochondrial matrix, converted to Acetyl-CoA by Pyruvate Dehydrogenase ($\text{PDH}$), and oxidized via the $\text{TCA}$ cycle.
  • Reducing equivalents: Cytosolic $\text{NADH}$ transfers electrons into mitochondria via shuttle mechanisms to power the Electron Transport Chain ($\text{ETC}$).
  • Overall ATP Yield: Complete oxidative breakdown of glucose yields approximately $34-36\,\text{ATP}$ molecules.

• Anaerobic Glycolysis:

  • Occurs in oxygen-deprived conditions (hypoxia/anoxia) or in cells lacking mitochondria (such as mature erythrocytes).
  • Final product: Lactate.
  • Mechanism of $\text{NAD}^+$ Regeneration:     $\text{Pyruvate} + \text{NADH} + \text{H}^+ \rightleftharpoons \text{Lactate} + \text{NAD}^+$
  • Enzyme: Lactate Dehydrogenase ($\text{LDH}$).
  • Purpose: Re-oxidizes cytosolic $\text{NADH}$ to $\text{NAD}^+$, maintaining the mandatory $\text{NAD}^+$ pool required by Glyceraldehyde 3-phosphate dehydrogenase (Step 6) to keep glycolysis functioning.
  • Net ATP Yield: Exactly $2\,\text{ATP}$ per glucose molecule.

The Cori Cycle and Lactate Utilization

• The Cori Cycle provides metabolic integration between non-hepatic peripheral tissues (such as exercising skeletal muscle and red blood cells) and the liver.
• Pathway Sequence:
  • Anaerobic glycolysis in non-hepatic tissues converts glucose into $2\,\text{Lactate}$, yielding $2\,\text{ATP}$.
  • Lactate diffuses into the bloodstream and is transported to the liver.
  • Hepatic Lactate Dehydrogenase ($\text{LDH}$) oxidizes lactate back to pyruvate.
  • Hepatic Gluconeogenesis converts $2\,\text{Pyruvate}$ into $1\,\text{Glucose}$, consuming $6\,\text{ATP}$.
  • Glucose is re-secreted into the circulation for reuse by peripheral tissues.
• Physiological Purpose: Clears circulating lactate produced during high glycolytic activity, preventing tissue acidosis while regenerating blood glucose.

Lactic Acidosis and Clinical Pathologies

• Diagnostic Criteria:
  • Blood lactate levels exceeding $5\,mM$ (normal range is $< 2\,mM$).
  • Blood pH falling below 7.35$.\n- **Biochemical Mechanism**:\n - An elevated cytosolic \text{NADH}/\text{NAD}^+$ratio inhibits pyruvate entry into mitochondrial pathways and drives the$\text{LDH} reaction toward excessive lactate formation.\n- **Etiologies of Increased \text{NADH}/\text{NAD}^+ Ratio and Lactic Acidosis**:\n - **Excessive Ethanol Consumption**:\n - Ethanol oxidation to Acetaldehyde by Alcohol Dehydrogenase (\text{ADH}$) generates cytosolic$\text{NADH}:\n      \text{CH}3\text{CH}_2\text{OH} + \text{NAD}^+ \rightarrow \text{CH}_3\text{CHO} + \text{NADH} + \text{H}^+\n - Acetaldehyde oxidation to Acetate by Aldehyde Dehydrogenase (\text{ALDH}$) generates additional$\text{NADH}:\n      \text{CH}_3\text{CHO} + \text{NAD}^+ \rightarrow \text{CH}_3\text{COO}^- + \text{NADH} + \text{H}^+\n - High cytosolic \text{NADH}$shifts$\text{LDH} equilibrium strongly toward lactate.\n - **Tissue Hypoxia and Anoxia**:\n - Respiratory failure or compromised circulation limits \text{O}_2$, halting$\text{ETC}$oxidation of$\text{NADH} and forcing anaerobic lactate production.\n - **Interruption of ETC or TCA Cycle**:\n - Ischemia (inadequate tissue perfusion).\n - Poisons: Cyanide and Carbon Monoxide (\text{CO}$) inhibit Complex IV, stopping electron flow and$\text{ATP} synthesis.\n - Mitochondrial DNA (mtDNA) mutations: Genetic defects in mtDNA-encoded subunits of Complex I, III, IV, or F_0F_1\text{-ATP} synthase reduce electron transport.\n - Nuclear genetic defects: Deficiencies in nuclear-encoded \text{TCA} cycle enzymes impair acetyl-CoA oxidation, increasing pyruvate and lactate levels.\n\n# Key Regulatory Points and Enzymatic Isoforms\n\n- **General Logic**: Glycolysis is primarily controlled by cellular energy charge. High \text{ATP}/\text{ADP}$ratios inhibit glycolytic activity, whereas low$\text{ATP}$combined with elevated$\text{AMP}$or$\text{ADP} stimulates glycolytic flux.\n- **Three Irreversible Control Sites**:\n - Site 1: Hexokinase / Glucokinase (Step 1)\n - Site 2: Phosphofructokinase-1 (Step 3)\n - Site 3: Pyruvate Kinase (Step 10)\n\n- **Site 1: Hexokinase versus Glucokinase Isoforms**\n\n  \n\n - **Hexokinase**:\n - Located in most tissues (such as skeletal muscle, brain, and erythrocytes).\n - Low K_m$for glucose ($\sim 0.1\,mM), corresponding to high affinity. Operates near maximum velocity even during fasting.\n - Low maximal velocity (V{\max}).\n - Allosterically inhibited by its product, Glucose 6-phosphate.\n - **Glucokinase**:\n - Located in liver hepatocytes and pancreatic \beta\text{-cells}.\n - High K_m$for glucose ($\sim 8\,mM), corresponding to low affinity. Active mainly after meals when blood glucose concentrations rise.\n - High maximal velocity (V_{\max}), facilitating rapid clearance of high postprandial glucose.\n - Not inhibited by Glucose 6-phosphate.\n - Physiological role: Ensures extrahepatic tissues have priority access to glucose during fasting, allowing hepatic glucose processing primarily when glucose is abundant.\n - **Pancreatic \beta\text{-cell} Glucose Sensing Mechanism**:\n\n    \n\n - Glucokinase functions as the glucose sensor in pancreatic \beta\text{-cells}.\n - Elevated circulating glucose increases glycolytic flux, elevating mitochondrial \text{ATP} generation.\n - Increased \text{ATP}/\text{ADP}$ratio closes$\text{ATP}$-sensitive potassium channels ($K_{\text{ATP}}).\n - Closure of K_{\text{ATP}}$channels depolarizes the cell membrane, opening Voltage-Dependent Calcium Channels ($\text{VDCC}).\n - Calcium (\text{Ca}^{2+}) influx triggers exocytosis of insulin granules.\n - **Maturity-Onset Diabetes of the Young Type 2 (MODY2)**:\n - Cause: Genetic deficiency/mutations in the glucokinase gene.\n - Mechanism: Mutations increase the K_m$of glucokinase (lowering glucose affinity), impairing$\beta\text{-cell} glucose sensing.\n - Clinical manifestation: Reduced insulin secretion resulting in mild fasting hyperglycemia and low serum C-peptide levels.\n\n- **Site 2: Phosphofructokinase-1 (PFK-1)**:\n - Primary rate-limiting enzyme of glycolysis.\n - Structure: Tetrameric protein with 6 binding sites (2 substrate sites for Fructose 6-P and \text{ATP}; 4 allosteric sites).\n - Allosteric Modulators:\n - Inhibitors: \text{ATP} and Citrate.\n - Activators: \text{AMP}$and Fructose 2,6-bisphosphate ($\text{F-2,6-BP}).\n - **Regulation in Muscle**:\n - During exercise, \text{ATP}$depletion causes$\text{AMP}$accumulation. High$\text{AMP}$overcomes$\text{ATP}$inhibition, activating$\text{PFK-1}$and boosting$\text{ATP} synthesis.\n - **Regulation in Liver by Fructose 2,6-bisphosphate**:\n\n    \n\n - \text{F-2,6-BP}$is synthesized and degraded by a single bifunctional enzyme ($\text{PFK-2/FBPase-2}):\n - \text{PFK-2}$domain synthesizes$\text{F-2,6-BP} from Fructose 6-P.\n - \text{FBPase-2}$domain hydrolyzes$\text{F-2,6-BP} back to Fructose 6-P.\n - **Fed State (High Insulin / Low Glucagon)**:\n - Activates protein phosphatases, dephosphorylating \text{PFK-2/FBPase-2}.\n - Dephosphorylated \text{PFK-2}$is active;$\text{FBPase-2} is inactive.\n - \text{F-2,6-BP}$levels rise, activating$\text{PFK-1} and promoting glycolysis.\n - **Fasting State (High Glucagon / Low Insulin)**:\n - Increases \text{cAMP}$, activating Protein Kinase A ($\text{PKA}$), which phosphorylates$\text{PFK-2/FBPase-2}.\n - Phosphorylated \text{FBPase-2}$is active;$\text{PFK-2} is inactive.\n - \text{F-2,6-BP}$levels drop, inactivating$\text{PFK-1} and inhibiting glycolysis to allow gluconeogenesis.\n\n- **Site 3: Pyruvate Kinase (PK)**:\n - Catalyzes conversion of Phosphoenolpyruvate (\text{PEP}) to Pyruvate.\n - Allosteric Regulation:\n - Activator: Fructose 1,6-bisphosphate (feed-forward activation).\n - Inhibitor: \text{ATP}.\n - **Hormonal Regulation in Liver**:\n - High Glucagon (\text{cAMP/PKA}$pathway) phosphorylates liver Pyruvate Kinase ($\text{PK}), turning the enzyme off.\n - Inactivation of \text{PK}$blocks$\text{PEP}$consumption in glycolysis, diverting$\text{PEP} into gluconeogenesis.\n\n- **Mitochondrial Entry Regulation: Pyruvate Dehydrogenase (PDH)**:\n - Controls conversion of Pyruvate to Acetyl-CoA.\n - Activators: \text{ADP}$and$\text{Ca}^{2+}.\n - Inhibitors: \text{NADH}$and$\text{Acetyl-CoA}.\n\n# Glycolytic Inhibitors, Toxins, and Inherited Deficiencies\n\n- **Mercury and Arsenic Poisoning**:\n - Directly inhibit Glyceraldehyde 3-phosphate dehydrogenase (\text{G3PDH}).\n - Halts glycolytic flux at Step 6, preventing energy production.\n\n- **Inorganic Phosphate Depletion and Hereditary Fructose Intolerance (HFI)**:\n - \text{G3PDH}$requires free inorganic phosphate ($\text{P}_i).\n - In HFI, a deficiency of Aldolase B leads to accumulation of trapped Fructose 1-phosphate.\n - Trapping depletes intracellular \text{P}_i$, halting the$\text{G3PDH}$reaction and causing secondary inhibition of glycolysis and hepatic$\text{ATP} depletion.\n\n- **Pyruvate Kinase or Phosphoglycerate Kinase Deficiency**:\n - Partial deficiency in Pyruvate Kinase or Phosphoglycerate Kinase leads to cellular \text{ATP} depletion.\n - Red blood cells require glycolytic \text{ATP}$to power$\text{Na}^+/\text{K}^+\text{-ATPase} membrane pumps.\n - Insufficient \text{ATP} causes cellular swelling, membrane disruption, lysis, and non-spherocytic hemolytic anemia.\n\n# Biosynthetic Precursors Derived from Glycolytic Intermediates\n\n\n\n- Glycolytic intermediates provide starting materials for major biosynthetic pathways:\n - **Glucose 6-Phosphate**: Feeds into the Pentose Phosphate Pathway to generate five-carbon sugars (Ribose 5-phosphate for \text{dNTP}$and nucleotide synthesis) and$\text{NADPH}.\n - **Dihydroxyacetone Phosphate (DHAP)**: Converted to Glycerol 3-phosphate, an essential backbone for triglyceride (\text{TG}) and phospholipid synthesis.\n - **1,3-Bisphosphoglycerate (1,3-BPG)**: In erythrocytes, converted to 2,3-Bisphosphoglycerate (\text{2,3-BPG}), an allosteric regulator that lowers hemoglobin oxygen affinity to facilitate oxygen unloading in tissues.\n - **3-Phosphoglycerate**: Direct precursor for Serine biosynthesis.\n - **Pyruvate**: Transaminated to yield Alanine.\n - **Acetyl-CoA**: Precursor for fatty acid and cholesterol synthesis, or entry into the \text{TCA}$$ cycle to generate Glutamate and other amino acids.